Genfit S.A. (GNFT)
NASDAQ: GNFT · IEX Real-Time Price · USD
3.970
-0.020 (-0.50%)
At close: Jul 2, 2024, 4:00 PM
3.980
+0.010 (0.25%)
After-hours: Jul 2, 2024, 4:00 PM EDT
Genfit Market Cap
Genfit has a market cap or net worth of $197.54 million as of July 2, 2024. Its market cap has decreased by -6.07% in one year.
Market Cap
197.54M
Enterprise Value
189.36M
1-Year Change
-6.07%
Ranking
Category
Stock Price
$3.97
Market Cap Chart
Since March 27, 2019, Genfit's market cap has decreased from $802.20M to $197.54M, a decrease of -75.37%. That is a compound annual growth rate of -23.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 2, 2024 | 197.80M | 3.07% |
| Dec 29, 2023 | 191.90M | -12.21% |
| Dec 30, 2022 | 218.60M | 12.45% |
| Dec 31, 2021 | 194.40M | 4.24% |
| Dec 31, 2020 | 186.50M | -74.10% |
| Dec 31, 2019 | 720.10M | -10.23% |
| Mar 27, 2019 | 802.20M | - |
View and export this data all the way back to 2019.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cybin | 201.24M |
| Akebia Therapeutics | 201.21M |
| The Joint | 200.50M |
| 2seventy bio | 198.42M |
| Butterfly Network | 198.07M |
| EDAP TMS | 196.65M |
| Inhibrx | 196.29M |
| Rani Therapeutics Holdings | 195.12M |